✦ LIBER ✦

Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia

✍ Scribed by Shibata, Takashi; Minami, Yosuke; Mitsuma, Ayako; Morita, Sachi; Inada-Inoue, Megumi; Oguri, Tomoyo; Shimokata, Tomoya; Sugishita, Mihoko; Naoe, Tomoki; Ando, Yuichi

Book ID: 120366182
Publisher: Springer
Year: 2013
Tongue: English
Weight: 167 KB
Volume: 19
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-013-0562-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UGT1A1*28and*6polymorphisms and nilotini

UGT1A1*28and*6polymorphisms and nilotinib-induced unconjugated hyperbilirubinemia in a Japanese patient with chronic myelogenous leukemia

✍ Kohichi Takada, Tsutomu Sato, Satoshi Iyama, Kaoru Ono, Yusuke Kamihara, Kazuyuk 📂 Article 📅 2012 🏛 Springer Japan ⚖ 215 KB

Associations between UGT1A1*6/*28 polymo

Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients

✍ Jing Gao, Jun Zhou, Yanyan Li, Zhi Peng, Yilin Li, Xicheng Wang… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 173 KB

Analysis of HLA-DRB1 alleles in Japanese

Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogenous leukemia

✍ Yasukawa, Masaki; Ohminami, Hideki; Kojima, Kensuke; Inokuchi, Koiti; Nishimura, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 2 views

To clarify the association between HLA-DRB1 alleles and chronic myelogenous leukemia (CML), the HLA-DRB1 allele frequencies in 50 Japanese patients each with b2a2 and b3a2 CML and 127 healthy Japanese individuals were examined. In the patients with b2a2 CML, the frequencies of HLA-DRB1\*0405, DRB1\*

444 POSTER Pharmacogenomic association b

444 POSTER Pharmacogenomic association between genetic polymorphism of UGT1A1 and serious toxicities occurring in the cancer patients receiving irinotecan-containing chemotherapy

✍ J.O. Kim; J.Y. Shin; J.R. Jang; M.A. Lee; H.S. Chae; I.K. Kim; H.S. Rhee; C.H. L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

UGT1A1*28 polymorphism predicts irinotec

UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

✍ Chun-Yu Liu; Po-Min Chen; Tzeon-Jye Chiou; Jin-Hwang Liu; Jen-Kou Lin; Tzu-Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

## Abstract ## BACKGROUND It is known that the uridine‐diphosphoglucuronosyl transferase 1A1 (UGT1A1)\*28 polymorphism reduces UGT1A1 enzyme activity, which may lead to severe toxicities in patients who receive irinotecan. This study was conducted to assess the influence of this polymorphism on th

Prognostic impact of deletions of deriva

Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib

✍ Alfonso Quintás-Cardama; Hagop Kantarjian; Jianqin Shan; Elias Jabbour; Lynne V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

## Abstract ## BACKGROUND: Deletions of derivative chromosome 9 are a poor prognostic factor in patients with chronic myeloid leukemia (CML) treated with hydroxyurea, interferon, or stem cell transplantation. Imatinib may overcome the adverse prognostic impact of deletions of derivative chromosome